BioCentury
ARTICLE | Clinical News

Abaloparatide-SC regulatory update

March 14, 2017 7:56 PM UTC

FDA extended by 3 months the PDUFA date for abaloparatide-SC to treat postmenopausal osteoporosis. The new PDUFA date is June 30. Radius said FDA is reviewing information the company submitted in resp...